SCHEMBL26656363

SCHEMBL26656363

O=CCN1c2ccc(F)cc2C[C@@H]1CF

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.34
GRIA2 P42262 4/20 0.33
GRIA1 P42261 3/20 0.33
GRIA3 P42263 3/20 0.33
GRIA4 P48058 3/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
NOTUM Q6P988 1/20 0.33
SLC6A2 P23975 7/20 0.32
SLC6A4 P31645 4/20 0.32
SLC6A3 Q01959 1/20 0.32
ROCK1 Q13464 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26656317 0.87 MAPK1 (0.36) MAPK1GRIA2GRIA1GRIA3GRIA4
SCHEMBL13267691 0.81 MAPK1 (0.42) MAPK1GRIA2GRIA1GRIA3GRIA4
SCHEMBL26656385 0.79 MAPK1 (0.33) MAPK1GRIA2GRIA1GRIA3GRIA4
SCHEMBL27178980 0.71 NOTUM (0.48) MAPK1ALDH1A1NPC1HTTRAB9A
SCHEMBL11595994 0.68 ALDH1A1 (0.36) MAPK1GRIA2GRIA1GRIA3GRIA4
SCHEMBL5352707 0.67 NOTUM (0.35) MAPK1ALDH1A1NPC1HTTRAB9A
SCHEMBL27416702 0.66 MAPK1 (0.44) MAPK1ALDH1A1NPC1HTTRAB9A
SCHEMBL12729547 0.65 ROCK1 (0.46) MAPK1GRIA2GRIA1GRIA3GRIA4
SCHEMBL26818531 0.63 NOTUM (0.48) MAPK1ALDH1A1NPC1HTTRAB9A
SCHEMBL26656347 0.61 POLB (0.38) MAPK1GRIA2GRIA1GRIA3GRIA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4526289-A1 ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-03-26 EP disclosed
WO-2023225162-A1 ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2023-11-23 WO disclosed